Expertise in
4
conditions

Pieter Gillard

Leuven, VLG, BE 
Expertise in
4
conditions
Leuven, VLG, BE 

Overview

Pieter Gillard practices practicing medicine in Leuven, Belgium.

Mr. Gillard is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Type 1 Diabetes (T1D), Low Blood Sugar, Agenesis of the Dorsal Pancreas, Islet Cell Transplantation, and Kidney Transplant.

He is actively involved in clinical research, co-authoring 114 peer reviewed articles and participating in 4 clinical trials.

Gender

Male

Locations

Leuven, VLG, Belgium
Other Locations
Brussels, BRU, Belgium
29, Rue Du Parc, Verviers, WAL 4800, Belgium
Belgium
Boulevard Du XII De Ligne, Liege, WAL 4000, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

The Impact of Hybrid Closed-loop Insulin Delivery (Medtronic MiniMed 670G and 780G System, Tandem t:Slim X2 Control-IQ, and Omnipod 5) on Glycemic Control and Patient-reported Outcomes in People Living With Type 1 Diabetes: a Multicenter Real-world Observational Study and Safety Study in Young Children (2-6 Years Old) in Belgium
The Impact of Hybrid Closed-loop Insulin Delivery (Medtronic MiniMed 670G and 780G System, Tandem t:Slim X2 Control-IQ, and Omnipod 5) on Glycemic Control and Patient-reported Outcomes in People Living With Type 1 Diabetes: a Multicenter Real-world Observational Study and Safety Study in Young Children (2-6 Years Old) in Belgium
Enrollment Status: Active_not_recruiting
Publish Date: May 27, 2026
Intervention Type: Device
A Phase 2, Multicentre, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of 400 mg Twice a Day Oral Ladarixin in Patients With New-onset Type 1 Diabetes
A Phase 2, Multicentre, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of 400 mg Twice a Day Oral Ladarixin in Patients With New-onset Type 1 Diabetes
Enrollment Status: Completed
Publish Date: April 19, 2024
Intervention Type: Drug
Study Phase: Phase 2
The Impact of Flash Glucose Monitoring on Clinical Outcome Parameters in Diabetes Patients
The Impact of Flash Glucose Monitoring on Clinical Outcome Parameters in Diabetes Patients
Enrollment Status: Completed
Publish Date: October 20, 2020
Evaluation of the Accuracy and Precision of Flash Glucose Monitoring Sensors in Different Sites: the Abdomen and Upper Thigh Compared to the Upper Arm
Evaluation of the Accuracy and Precision of Flash Glucose Monitoring Sensors in Different Sites: the Abdomen and Upper Thigh Compared to the Upper Arm
Enrollment Status: Completed
Publish Date: August 07, 2017
Intervention Type: Device
Study Phase: Not Applicable
View 3 Less Clinical Trials

114 Total Publications

CGM Metrics and the Risk of Pregnancy Complications in Type 1 Diabetes: A Secondary Exploratory Analysis of the CRISTAL Trial.
CGM Metrics and the Risk of Pregnancy Complications in Type 1 Diabetes: A Secondary Exploratory Analysis of the CRISTAL Trial.
Journal: Diabetes technology & therapeutics
Published: August 12, 2026

Frequently Asked Questions about Pieter Gillard

Is Pieter Gillard a top-rated expert for Type 1 Diabetes (T1D)?

MediFind is an objective health platform that identifies experts based on real-world data. Pieter Gillard is classified as an Distinguished expert for Type 1 Diabetes (T1D), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Pieter Gillard participate in research or clinical trials?

Yes. Pieter Gillard has published 114 articles and abstracts on conditions like Type 1 Diabetes (T1D). You can view a list of Pieter Gillard's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Gillard's expertise for a condition
ConditionClose
    View All 16 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile